Background Preoperative histologic examination of tumour tissue is essential when deciding
if endometrial cancer surgery should include lymph node sampling. We wanted to …

Purpose: Overexpression of the oncogen Stathmin has been linked to aggressive
endometrial carcinoma and a potential for PI3Kinase inhibitors in this disease. We wanted to …

Background Every year approximately 74,000 women die of endometrial cancer, mainly due
to recurrent or metastatic disease. The presence of tumor infiltrating lymphocytes (TILs) as …

OBJECTIVE: Endometrial cancer patients may benefit from systemic adjuvant
chemotherapy, alone or in combination with targeted therapies. Prognostic and predictive …

Objectives This study aimed to compare the prognosis of patients with synchronous
endometrial and ovarian cancer (SEOC) to matched controls with either endometrial cancer …

Objective To evaluate whether opportunistic salpingectomy in premenopausal women
undergoing hysterectomy for benign indications is both hormonally and surgically safe …

Background Endometrial carcinoma is the most common gynaecologic malignancy in
industrialised countries and the incidence is still rising. Primary treatment is based on …

Background: It is poorly described how endometrial cancer biology changes during tumor
evolution. We hypothesize that characterization of molecular targets in recurrent lesions is …

Objective: To assess the impact of adjuvant chemotherapy in early surgically staged type II
endometrial cancer (serous [S], clear cell carcinoma [CC]) and carcinosarcomas (CS) on …

Objective: To evaluate the response of dose-dense paclitaxel/carboplatin (TC) patients with
primarily advanced or recurrent endometrial cancer. Methods: Six courses of paclitaxel (90 …